| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |